9 Results for "

TM-2

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "TM-2" in MCE Product Catalog:

Cat. No.: HY-136882
CAS No.: 921099-13-0
Purity:  95.04%
Target:  

PDHK

Research Areas:  

Cancer

TM-1 is a potent inhibitor of pyruvate dehydrogenase kinase (PDHK1). TM-1 inhibits PDHK1 and PDHK2 with IC50s of 2.97 μM and 5.2 μM, respectively. TM-1 blocks pyruvate dehydrogenase complex (PDHC) phosphorylation, and inhibits cell proliferation .
loading...
    loading...
Cat. No.: HY-163173
CAS No.: 1008768-41-9
Target:  

YAP

Research Areas:  

Cancer

TEAD-IN-8 is a novel TEAD inhibitor, which potently and specifically inhibits TEAD-YAP transcriptional activities. TM2, alone or in combination with MEK inhibitors, exhibits potent antiproliferative effects in YAP-dependent cancer cells .
loading...
    loading...
Cat. No.: HY-121493
CAS No.: 1197196-47-6
Purity:  98.37%
Research Areas:  

Infection

TM2-115 inhibits malaria parasite histone methyltransferases, resulting in rapid and irreversible parasite death .
loading...
    loading...
Cat. No.: HY-RS14605
Research Areas:  

Others

TM2D3 Human Pre-designed siRNA Set A contains three designed siRNAs for TM2D3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-143863
CAS No.: 2697129-55-6
Target:  

PPAR

Research Areas:  

Metabolic Disease

Pparδ agonist 8 is a potent agonist of Pparδ. The peroxisome proliferator-activated receptor (PPAR) is a member of the intranuclear receptor transcription factor superfamily that plays a key role in the regulation of metabolic homeostasis, inflammation, cell growth and differentiation in vivo. Pparδ agonist 8 has the potential for the research of non-alcoholic fatty liver disease (NAFLD) (extracted from patent WO2021169769A1, compound TM2) .
loading...
    loading...
Cat. No.: HY-W274807
CAS No.: 4921-82-8
TM-2-51 is a HDAC8 activator with a Kd value of 0.28 μM. TM-2-51 inhibits α-glucosidase with an IC50 of 171.21 μM. TM-2-51 upregulates HDAC8 expression, modulates the TP53, STAT3/ERK and PI3K-AKT pathways, alleviates LeTx-induced cell cycle arrest, downregulates JMJD3 and increases H3K27me3 levels. TM-2-51 selectively induces apoptosis in tumor cell and upregulates p53/p21 expression. TM-2-51 inhibits tumor cell proliferation, migration and invasion, induces G1-phase arrest and suppresses tumor growth in vivo. TM-2-51 can be used in research on osteosarcoma, anthrax, type 2 diabetes and neuroblastoma [2] .
loading...
    loading...
Cat. No.: HY-P77238
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: TM2 domain-containing protein 1; Amyloid-beta-binding protein; hBBP; BBP
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-156921
CAS No.: 827603-95-2
Synonyms: 24-Bromofusidic acid; TD-1414
Target:  

Drug Derivative

Research Areas:  

Others

Zibrofusidic acid (24-Bromofusidic acid; TD-1414) is a brominated derivative of Fusidic acid (HY-B1350). Zibrofusidic acid can be combined within the hydrophobic groove formed by the transmembrane helix 1 (TM1) and the transmembrane helix 2 (TM2) of the AcrB protein. Zibrofusidic acid can be used for the research of multidrug efflux pump .
loading...
    loading...
Cat. No.: HY-RS17596
Research Areas:  

Others

Tpm1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Tpm1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...